Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | p450 reductase, putative | 0.0145 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0055 | 0.2894 | 0.2253 |
Trypanosoma cruzi | NADPH--cytochrome P450 reductase, putative | 0.0055 | 0.2894 | 0.2253 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0145 | 1 | 1 |
Trypanosoma brucei | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0055 | 0.2894 | 0.2253 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.4361 | 0.0274 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0145 | 1 | 1 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0145 | 1 | 1 |
Treponema pallidum | flavodoxin | 0.0055 | 0.2894 | 0.5 |
Brugia malayi | flavodoxin family protein | 0.0055 | 0.2894 | 0.2894 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0074 | 0.4361 | 0.4361 |
Plasmodium vivax | flavodoxin domain containing protein | 0.0128 | 0.8692 | 0.8574 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0145 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.0074 | 0.4361 | 0.4361 |
Brugia malayi | MH2 domain containing protein | 0.0139 | 0.9553 | 0.9553 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0145 | 1 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0145 | 1 | 1 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0145 | 1 | 1 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0145 | 1 | 1 |
Echinococcus multilocularis | methionine synthase reductase | 0.0089 | 0.5598 | 0.2194 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0139 | 0.9553 | 0.9512 |
Trypanosoma cruzi | p450 reductase, putative | 0.0145 | 1 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0089 | 0.5598 | 0.5201 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0145 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0145 | 1 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0055 | 0.2894 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0128 | 0.8692 | 0.5 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0055 | 0.2894 | 0.5 |
Leishmania major | cytochrome P450 reductase, putative | 0.0128 | 0.8692 | 0.8574 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0145 | 1 | 1 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0145 | 1 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0145 | 1 | 1 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0145 | 1 | 1 |
Plasmodium falciparum | NADPH--cytochrome P450 reductase, putative | 0.0055 | 0.2894 | 0.2253 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0072 | 0.4202 | 1 |
Plasmodium falciparum | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0055 | 0.2894 | 0.2253 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.4361 | 0.0274 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0055 | 0.2894 | 0.2253 |
Brugia malayi | RNA binding protein | 0.0074 | 0.4361 | 0.4361 |
Loa Loa (eye worm) | TAR-binding protein | 0.0074 | 0.4361 | 0.3852 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.4361 | 0.0274 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0145 | 1 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0089 | 0.5598 | 0.2407 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0055 | 0.2894 | 0.5 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0128 | 0.8692 | 0.5 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0128 | 0.8692 | 0.8159 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0073 | 0.429 | 0.0151 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0145 | 1 | 1 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0055 | 0.2894 | 0.2253 |
Loa Loa (eye worm) | RNA binding protein | 0.0074 | 0.4361 | 0.3852 |
Plasmodium vivax | hypothetical protein, conserved | 0.0055 | 0.2894 | 0.2253 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.4361 | 0.0274 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0139 | 0.9553 | 0.9512 |
Brugia malayi | hypothetical protein | 0.0029 | 0.0828 | 0.0828 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0074 | 0.4361 | 0.3852 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0145 | 1 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0145 | 1 | 0.5 |
Echinococcus granulosus | methionine synthase reductase | 0.0089 | 0.5598 | 0.2194 |
Chlamydia trachomatis | sulfite reductase | 0.0089 | 0.5598 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.4361 | 0.0274 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0072 | 0.4202 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0055 | 0.2894 | 0.5 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0055 | 0.2894 | 0.5 |
Loa Loa (eye worm) | flavodoxin family protein | 0.0055 | 0.2894 | 0.2253 |
Brugia malayi | FAD binding domain containing protein | 0.0089 | 0.5598 | 0.5598 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0145 | 1 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0145 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.